Medicared For All Logo

Max Rabinowitz MD in Anchorage, Alaska

Home Alaska Anchorage

Max Rabinowitz MD has Hematology/oncology as his primary medical specialty. Their primary office is: 2925 Debarr Rd in Anchorage, Alaska.

They're a part of the: Alaska Oncology And Hematology Llc medical group which has around 9 members. You can call their office at 907-279-3155 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Washington School Of Medicine and graduated in 1999 (around 25 years of experience). They are listed as doing telehealth appointments.


Max J Rabinowitz MD Office Phone and Directions

Max Rabinowitz MD
Alaska Oncology And Hematology Llc
2925 Debarr Rd
Anchorage, Alaska 99508
907-279-3155


Patient Ratings
Please rate your experience with Max Rabinowitz MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 907-279-3155


Enter a starting address:


Healthcare Info for Max Rabinowitz MD

Medical School: University Of Washington School Of Medicine
Graduation Year: 1999
The Primary Medical Specialty for Max Rabinowitz MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 4284606617
NPI #: 1295770972
NPI Created On: 06/18/2006
NPI Last Updated Listed as: 11/22/2021
Primary Taxonomy Code: 207RH0003X
License Number:
AA5346
Listed Gender: Male

Procedures, Services, Charges


Services and Procedures include:

  1. Ct scan chest with contrast
  2. Ct scan of abdomen and pelvis with contrast
  3. Vaccine for influenza for administration into muscle, 0.5 ml dosage
  4. Hydration infusion into a vein 31 minutes to 1 hour
  5. Hydration infusion into a vein
  6. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  7. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  8. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  9. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  10. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  11. Infusion of different chemotherapy drug or substance into a vein
  12. Infusion of chemotherapy into a vein up to 1 hour
  13. Infusion of chemotherapy into a vein
  14. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  15. Irrigation of implanted venous access drug delivery device
  16. New patient office or other outpatient visit, typically 30 minutes
  17. New patient office or other outpatient visit, typically 45 minutes
  18. Established patient office or other outpatient visit, typically 10 minutes
  19. Established patient office or other outpatient visit, typically 15 minutes
  20. Established patient office or other outpatient, visit typically 25 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788086575

Being Disputed:: No

Product Related: No


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788086577

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781014047

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803052397

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832160879

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783723857

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hematology

Name of Drug #1: Revlimid

Open Associated Drug #1: 59572-405-28


Payments Total: $19

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783723863

Being Disputed:: No

Product Related: Yes


Payments Total: $25

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783723875

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01


Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783626865

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835949189

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Alecensa

Open Associated Drug #1: 50242-130-01

Drug or Biological: Biological

Product Category #2: BioOncology

Name Of Drug #2:: TECENTRIQ

Associated Drug #2: 50242-917-01

Drug or Biological #3:: Biological

Product Category #3: BioOncology

Name of Drug: ROZLYTREK

Name Of Drug #3: 50242-091-30


Hematology/oncology Professionals in Anchorage

4100 Lake Otis Pkwy
Anchorage, AK

3900 Ambassador Dr
Anchorage, AK
Alaska Native Tribal Health Consortium

2925 Debarr Rd
Anchorage, AK
Alaska Oncology And Hematology Llc

3900 Ambassador Dr
Anchorage, AK
Alaska Native Tribal Health Consortium

4315 Diplomacy Dr
Anchorage, AK
Alaska Native Tribal Health Consortium

3851 Piper St
Anchorage, AK
Katmai Oncology Group Llc

Providers in Alaska Oncology And Hematology Llc

1.Mary Klix Md

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Medical Oncology

2.Steven Liu Md

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Medical Oncology

3.Max Rabinowitz Md

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Hematology/oncology

4.Jeremy Rosiecki

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Physician Assistant

5.Mary Stewart

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Hematology/oncology

6.Pamela Tittle

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Physician Assistant

View all 9 members of Alaska Oncology And Hematology Llc medical group